Tilray Brands, Inc. (TLRY) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Tilray Brands, Inc. (TLRY) Healthcare & Pipeline Overview

Tilray Brands, Inc. operates as a global cannabis-lifestyle CPG company, focusing on the research, cultivation, production, and distribution of medical and recreational cannabis products, beverage alcohol, and wellness products across Canada, the United States, Europe, and other international markets, positioning itself within the expanding global cannabis industry.

What Is the Investment Thesis for TLRY?

Tilray Brands, Inc. presents a multifaceted investment thesis predicated on its diversified business model and strategic positioning within the evolving cannabis and consumer packaged goods industries. Key value drivers include the expansion of its cannabis business in both medical and recreational markets, leveraging its established brands and distribution networks. The growth of its beverage alcohol segment, particularly through acquisitions like Breckenridge Distillery, offers diversification and revenue stability. A potential catalyst is the further legalization of cannabis in key markets, such as the United States and Europe, which could significantly expand Tilray's market access. However, investors may want to evaluate the risks associated with regulatory uncertainty, intense competition, and the company's current negative profit margin of -156.2%.

Based on FMP financials and quantitative analysis

TLRY Key Highlights

Tilray Brands operates in four segments: Cannabis, Distribution, Beverage Alcohol, and Wellness, diversifying its revenue streams.

• The company's gross margin stands at 27.7%, reflecting its ability to manage production costs and pricing strategies.
• Tilray's beta of 2.11 indicates higher volatility compared to the broader market, potentially offering higher returns but also greater risk.
• Tilray has a global presence, operating in Canada, the United States, Europe, Australia, and Latin America, reducing reliance on any single market.
• Tilray's diversified brand portfolio, including Tilray, Aphria, SweetWater, and Breckenridge Distillery, caters to a wide range of consumer preferences.

Who Are TLRY's Competitors?

TLRY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are TLRY's Key Strengths?

Diversified business model across cannabis, beverage alcohol, and wellness.

• Global presence and distribution network.
• Strong brand recognition in the cannabis industry.
• GMP-certified production facilities.

What Are TLRY's Weaknesses?

Negative profit margin.

• High beta indicating higher volatility.
• Dependence on regulatory changes in the cannabis industry.
• Intense competition in the cannabis and beverage alcohol markets.

What Could Drive TLRY Stock Higher?

TLRY catalyst: Potential federal legalization of cannabis in the United States, which could significantly expand Tilray's market access.

• Expansion of cannabis operations in Europe, Australia, and Latin America.
• Growth in the beverage alcohol segment through strategic acquisitions and organic growth.
• Development of new and innovative cannabis products.

What Are the Key Risks for TLRY?

Financial-distress signal — its Altman Z-Score of -1.98 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-8.0%) — the business is not currently generating profit on shareholder capital.
• Inconsistent delivery — missed Wall Street EPS estimates in 6 of the last 8 reported quarters.
• Regulatory uncertainty in the cannabis industry.
• Intense competition from other cannabis companies and beverage alcohol producers.
• Fluctuations in cannabis prices and demand.
• Product recalls or safety concerns.
• Negative profit margin impacting financial performance.

What Are the Growth Opportunities for TLRY?

• Expansion in the U.S. Cannabis Market: With potential federal legalization on the horizon, Tilray can leverage its existing infrastructure and brand recognition to rapidly expand its presence in the U.S. cannabis market. Timeline: Ongoing, with potential acceleration upon federal legalization.
• Growth in the Beverage Alcohol Segment: Tilray can continue to expand its beverage alcohol business through strategic acquisitions and organic growth of its existing brands, such as Breckenridge Distillery and SweetWater. The global alcoholic beverage market is a multi-billion dollar industry, providing ample opportunity for Tilray to increase its market share. Timeline: Ongoing.
• International Expansion in Cannabis: Tilray can further expand its cannabis operations in Europe, Australia, and Latin America, capitalizing on the increasing legalization and acceptance of cannabis in these regions. The international cannabis market is projected to experience significant growth in the coming years, offering substantial opportunities for Tilray. Timeline: Ongoing.
• Development of New Cannabis Products: Tilray can invest in research and development to create new and innovative cannabis products, catering to evolving consumer preferences and demands. This includes developing new edibles, topicals, and other cannabis-infused products. Timeline: Ongoing.
• Strategic Partnerships and Acquisitions: Tilray can pursue strategic partnerships and acquisitions to expand its product portfolio, distribution network, and geographic reach. This includes partnering with other cannabis companies, beverage alcohol producers, and wellness product manufacturers. Timeline: Ongoing.

What Are TLRY's Competitive Advantages?

• Brand recognition and reputation in the cannabis industry.
• Global presence and distribution network.
• Diversified product portfolio across cannabis, beverage alcohol, and wellness.
• GMP-certified production facilities ensuring product quality and consistency.

What Does TLRY Do?

Tilray Brands, Inc., headquartered in Leamington, Canada, is a global cannabis-lifestyle consumer packaged goods company. Originally known as Tilray, Inc., the company has evolved through strategic mergers and acquisitions to broaden its portfolio beyond cannabis. Tilray's operations span across four key segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business focuses on the cultivation, production, marketing, and distribution of medical and adult-use cannabis products, including flowers, oils, vapes, edibles, and topicals. These products are GMP-certified, ensuring quality and consistency. The Distribution Business involves the purchase and resale of pharmaceutical and wellness products, expanding Tilray's reach into related markets. The Beverage Alcohol Business produces, markets, sells, and distributes a range of alcoholic beverages, diversifying Tilray's revenue streams. The Wellness Business focuses on hemp-based food and other wellness products, catering to health-conscious consumers. Tilray's products are marketed under a variety of brands, including Tilray, Aphria, Broken Coast, SweetWater, and Breckenridge Distillery. The company sells its products through various channels, including retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, governments, and direct to consumers, establishing a broad distribution network.

What Products and Services Does TLRY Offer?

• Researches and develops medical cannabis products.
• Cultivates and produces cannabis flowers, oils, vapes, edibles, and topicals.
• Markets and distributes medical and adult-use cannabis products.
• Purchases and resells pharmaceutical and wellness products.
• Produces, markets, and sells beverage alcohol products.
• Offers hemp-based food and other wellness products.
• Sells products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments.
• Sells products directly to consumers.

How Does TLRY Make Money?

• Cultivation and production of cannabis products for medical and recreational use.
• Distribution of cannabis, pharmaceutical, and wellness products through various channels.
• Production and sale of beverage alcohol products.
• Direct-to-consumer sales through online platforms and retail locations.

What Industry Does TLRY Operate In?

Tilray Brands operates within the rapidly evolving cannabis and consumer packaged goods industries. The beverage alcohol industry is a mature market, but Tilray's strategic acquisitions in this space provide diversification and access to established distribution channels. The competitive landscape includes other major cannabis companies, established beverage alcohol producers, and wellness product manufacturers. Tilray's diversified business model and global presence position it to capitalize on growth opportunities in these dynamic markets.

Who Are TLRY's Key Customers?

• Medical patients seeking cannabis for therapeutic purposes.
• Adult-use consumers seeking cannabis for recreational purposes.
• Retailers and wholesalers distributing cannabis products.
• Hospitals, pharmacies, and research institutions using cannabis for medical research and treatment.
• Consumers of beverage alcohol and wellness products.

Tilray Brands, Inc. (TLRY) Valuation Context

Valued at $463M, TLRY is classified as a small-cap stock. Analyst price targets span from $10.00 to $190.00, with a consensus of $65.01. At the current price of $4.14, that implies approximately 1470% upside potential. Relative to its peer group, TLRY's quantitative score of 16/100 is below the peer average of 59/100.

TLRY Revenue & Earnings Trend

In Q4 FY2026, TLRY generated $281.7M in top-line revenue, marking a sequential decrease of 0.2%. The company recorded a net loss of $49.6M, with diluted EPS of $-0.43. Revenue has contracted over three consecutive quarters, which investors in this small-cap Healthcare stock should monitor closely. Across the four most recent quarters, TLRY averaged $-0.33 in diluted EPS.

Company Profile

Tilray Brands, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Leamington, CA. The company is led by CEO Irwin David Simon. TLRY has traded publicly since 2018.

Return on equity for Tilray Brands, Inc. stands at -8.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -6.4%, showing how much profit it generates from its asset base. Its free cash flow yield is -22.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.21 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -29.4%, the inverse of the P/E and a quick read on earnings relative to price.

Tilray Brands, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.98 places it in the distress zone, a signal of elevated financial risk.

Tilray Brands, Inc. has missed Wall Street's EPS estimate in 6 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 880.6% below estimates on average.

Over the past six months, Tilray Brands, Inc. insiders filed 30 SEC Form 4 transactions — 16 sales and 14 purchases. On net that is roughly 675K shares acquired (about $5.6M) — insiders putting money in tends to read as conviction.

TLRY Financials

TLRY Latest News

TLRY Analyst Consensus

TLRY MoonshotScore

Latest Tilray Brands, Inc. Analysis

What Investors Ask About Tilray Brands, Inc. (TLRY) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources